Concurrent endometrial intraepithelial carcinoma (EIC) and serous ovarian cancer: Can EIC be seen as the precursor lesion?

International Journal of Gynecological Cancer

Volumn 22, Issue 3, 2012, Pages 457-464

  Roelofsen, Thijs ^a   Van Kempen, Léon C L T ^a,b   Van Der Laak, Jeroen A W M ^a   Van Ham, Maaike A ^a   Bulten, Johan ^a   Massuger, Leon F A G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Endometrial intraepithelial carcinoma; Lesion of origin; Ovarian carcinoma; Precursor

Indexed keywords

ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; PROTEIN P53;

ADULT; AGED; ARTICLE; DNA DETERMINATION; ENDOMETRIAL INTRAEPITHELIAL CARCINOMA; ENDOMETRIUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PLOIDY; PRIORITY JOURNAL; SEROUS OVARIAN CARCINOMA;

AGED; AGED, 80 AND OVER; CARCINOMA IN SITU; COHORT STUDIES; CYSTADENOCARCINOMA, SEROUS; DNA MUTATIONAL ANALYSIS; ENDOMETRIAL NEOPLASMS; FEMALE; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; OVARIAN NEOPLASMS; PLOIDIES; PRECANCEROUS CONDITIONS;

EID: 84858259910     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e3182434a81     Document Type: Article

References (25)

1. Gwinn ML, Lee NC, Rhodes PH, et al. Pregnancy, breast feeding, and oral contraceptives and the risk of epithelial ovarian cancer. J Clin Epidemiol. 1990;43:559-568. (Pubitemid 20178545)
2. Moorman PG, Calingaert B, Palmieri RT, et al. Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal women. Am J Epidemiol. 2008;167:1059-1069. (Pubitemid 351601240)
3. Cramer DW, Welch WR. Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst. 1983;71:717-721. (Pubitemid 14232385)
4. Fathalla MF. Incessant ovulation - a factor in ovarian neoplasia? Lancet. 1971;2:163.
5. Crum CP, Drapkin R, Miron A, et al. The distal fallopian tube: a new model for pelvic serous carcinogenesis. Curr Opin Obstet Gynecol. 2007;19:3-9. (Pubitemid 46095865)
6. Piek JM, Kenemans P, Verheijen RH. Intraperitoneal serous adenocarcinoma: a critical appraisal of three hypotheses on its cause. Am J Obstet Gynecol. 2004;191:718-732. (Pubitemid 39298100)
7. Callahan MJ, Crum CP, Medeiros F, et al. Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J Clin Oncol. 2007;25:3985-3990. (Pubitemid 47477278)
8. Crum CP, Drapkin R, Kindelberger D, et al. Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer. Clin Med Res. 2007;5:35-44. (Pubitemid 350218778)
9. Finch A, Shaw P, Rosen B, et al. Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers. Gynecol Oncol. 2006;100:58-64. (Pubitemid 41815050)
10. Massuger L, Roelofsen T, Ham MV, et al. The origin of serous ovarian cancer may be found in the uterus: a novel hypothesis. Med Hypotheses. 2010;74:859-861.
11. Ambros RA, Sherman ME, Zahn CM, et al. Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation. Hum Pathol. 1995;26:1260-1267.
12. Hendrickson M, Ross J, Eifel P, et al. Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol. 1982;6:93-108. (Pubitemid 12108965)
13. Zheng W, Schwartz PE. Serous EIC as an early form of uterine papillary serous carcinoma: recent progress in understanding its pathogenesis and current opinions regarding pathologic and clinical management. Gynecol Oncol. 2005;96:579-582. (Pubitemid 40255473)
14. Kupryjanczyk J, Thor AD, Beauchamp R, et al. Ovarian, peritoneal, and endometrial serous carcinoma: clonal origin of multifocal disease. Mod Pathol. 1996;9:166-173. (Pubitemid 26126539)
15. Chiaffarino F, Parazzini F, Decarli A, et al. Hysterectomy with or without unilateral oophorectomy and risk of ovarian cancer. Gynecol Oncol. 2005;97:318-322. (Pubitemid 40614870)
16. Cramer DW, Xu H. Epidemiologic evidence for uterine growth factors in the pathogenesis of ovarian cancer. Ann Epidemiol. 1995;5:310-314.
17. Hankinson SE, Hunter DJ, Colditz GA, et al. Tubal ligation, hysterectomy, and risk of ovarian cancer. A prospective study. JAMA. 1993;270:2813-2818. (Pubitemid 23361643)
18. Irwin KL, Weiss NS, Lee NC, et al. Tubal sterilization, hysterectomy, and the subsequent occurrence of epithelial ovarian cancer. Am J Epidemiol. 1991;134:362-369.
19. Loft A, Lidegaard O, Tabor A. Incidence of ovarian cancer after hysterectomy: a nationwide controlled follow up. Br J Obstet Gynaecol. 1997;104:1296-1301. (Pubitemid 27485499)
20. Rosenblatt KA, Thomas DB. Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. Cancer Epidemiol Biomarkers Prev. 1996;5:933-935.
21. Baergen RN, Warren CD, Isacson C, et al. Early uterine serous carcinoma: clonal origin of extrauterine disease. Int J Gynecol Pathol. 2001;20:214-219. (Pubitemid 32578105)
22. Jarboe EA, Miron A, Carlson JW, et al. Coexisting intraepithelial serous carcinomas of the endometrium and fallopian tube: frequency and potential significance. Int J Gynecol Pathol. 2009;28:308-315.
23. Blokx WA, Ruiter DJ, Verdijk MA, et al. INK4-ARF and p53 mutations in metastatic cutaneous squamous cell carcinoma: case report and archival study on the use of Ink4a-ARF and p53 mutation analysis in identification of the corresponding primary tumor. Am J Surg Pathol. 2005;29:125-130. (Pubitemid 40023961)
24. Fleskens SJ, Takes RP, Otte-Holler I, et al. Simultaneous assessment of DNA ploidy and biomarker expression in paraffin-embedded tissue sections. Histopathology. 2010;57:14-26.
25. van der Avoort IA, van de Nieuwenhof HP, Otte-Holler I, et al. High levels of p53 expression correlate with DNA aneuploidy in (pre)malignancies of the vulva. Hum Pathol. 2010;41:1475-1485.